Market Cap

Healios K.K. Market Capitalization:

¥55.98 Billion

JPY as of Jan. 1, 2026

US$357.2 Million

business Healios K.K. Company Profile

Healios K.K. Main Stock Listing

JPX: 4593

Market Capitalization History of Healios K.K.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Healios K.K. market cap

Date Market Cap YoY Change
Jan. 1, 2026 ¥55.98 B 263.20%
Jan. 1, 2025 ¥15.41 B 25.31%
Jan. 1, 2024 ¥12.30 B -25.41%
Jan. 1, 2023 ¥16.49 B -73.29%
Jan. 1, 2022 ¥61.73 B -35.31%
Jan. 1, 2021 ¥95.43 B -11.83%
Jan. 1, 2020 ¥108.22 B 10.25%
Jan. 1, 2019 ¥98.16 B -20.34%
Jan. 1, 2018 ¥123.23 B 6.48%
Jan. 1, 2017 ¥115.73 B 81.68%
Jan. 1, 2016 ¥63.70 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Healios K.K. Categories

Japan languages Healthcare languages Biotechnology
Japan Healthcare Japan Biotechnology

Stocks & Indices

Healios K.K. has the following listings and related stock indices.


Stock: JPX: 4593

Stock: FSX: 6VX

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.